U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07789743) titled 'Stop Transmission of Gambiense Human African Trypanosomiasis' on Aug. 04.
Brief Summary: This protocol describes both the epidemiological study which aims at assessing whether over a three-year period a zero prevalence can be achieved when implementing a screen & treat approach with acoziborole, as well as a nested clinical study aimed at generating further evidence on safety of acoziborole in gambiense human African trypanosomiasis (gHAT) seropositives individuals. The overall coordinator will be ITM. ITM will be fully responsible for the epidemiological study (study Part A), including cost effectiveness and evaluation of diagnosti...